Novavax seeks WHO approval for emergency listing of COVID-19 vaccine A spokesperson for the company said the submission to Canadian health authorities comes as Novavax received recent approval for use in Indonesia.
It also intends to follow up and do a “completion of data submission in the European Union.” The company has been busy across the globe with another provisional approval application made for the vaccine in Australia on Oct.